FDA Grants CLIA Waiver to Rapid Screening Test for Syphilis
FDA’s action will permit the Syphilis Health Check test to be used by untrained healthcare workers in a variety of nontraditional settings.
Read MorePosted by Steve Halasey | Dec 30, 2014 | Compliance, Infectious Diseases, Sexually Transmitted Diseases |
FDA’s action will permit the Syphilis Health Check test to be used by untrained healthcare workers in a variety of nontraditional settings.
Read MorePosted by Jenny Lower | Dec 29, 2014 | Flu & Respiratory Infections, Infectious Diseases |
The Simplexa Flu A/B & RSV Direct kit from Focus Diagnostics, Cypress, Calif, has received FDA clearance for eight additional influenza strains, including H3N2v and the novel avian influenza A strain H7N9.
Read MorePosted by Jenny Lower | Dec 18, 2014 | Cleaners & Disinfectants, Labwear & Consumables, Uncategorized |
Featured products include the Cytation 5 cell imaging multimode readerfrom BioTek, an ebola disinfectant from Mueller Sports Medicine, and a lab coat with multiple pockets for electronic devices from ScotteVest.
Read MorePosted by Steve Halasey | Dec 15, 2014 | Infectious Diseases, Molecular Diagnostics |
Abbott says its latest platform has the potential to change how serious infections are detected and identified, providing doctors with information needed to start treating critically ill patients sooner, and reducing inappropriate use of broad-spectrum antibiotics.
Read MorePosted by Jenny Lower | Dec 15, 2014 | Sexually Transmitted Diseases |
FDA has granted CLIA-waived status to the Alere Determine HIV-1/2 Ag/Ab Combo test, making it eligible for use in physician offices and clinics. The fourth-generation test enables faster detection, within days of infection.
Read More